Feb 11 (Reuters) - Abbvie sued the U.S. Department of Health and Human Services on Wednesday, challenging a decision by the ...

AbbVie Inc. is challenging the Trump administration’s decision to select its Botox drug for a government program that slashes ...

The needles didn’t sting as badly as Jazlyn Miller feared — just a quick pinch, exactly like her mom promised. The ...

While the treatment helped her TMJ-related pain, Bailey Turner tells PEOPLE it left her face feeling "completely frozen" ...

More than a billion people worldwide struggle to find relief from the unbearable pain of migraine. But research is leading to ...

AbbVie contends that Botox should have been excluded from the IRA drug price negotiation program because it is a plasma-derived product.

By Deanna Neff HealthDay ReporterTHURSDAY, Jan. 29, 2026 (HealthDay News) — Fifteen prescription medications, including Botox and the diabetes drug Trulicity, will be the focus of federal price ...

Kaley Cuoco, 40, confessed her first round of Botox treatments didn’t have the effect she desired. Instead, the jabs left her ...

In response to last month’s list of the 15 drugs chosen by the Centers for Medicare & Medicaid Services (CMS) for upcoming price cuts under the Inflation Reduction Act (IRA), AbbVie is the late | The ...